Skip to main content
. 2000 May;156(5):1581–1588. doi: 10.1016/S0002-9440(10)65030-4

Figure 3.

Figure 3.

Control specimens. A: Normal proliferative endometrial samples had no evidence of EPO when immunostained with the monoclonal antibody directed against EPO. B: Substitution of an irrelevant monoclonal antibody (negative control) for the anti-EPO antibody produced no staining of any of the tissues, including the endometriosis sample shown here.